Future Table of Contents: May 1, 2008; 7 (5)

Spotlight on Clinical Response

Review

Research Articles

Spotlight on Clinical Response

Hong, D. et al.

Medullary thyroid cancer: targeting the RET kinase pathway with orafenib/tipifarnib

Review

Su, H. et al.

Competitive or noncompetitive, that’s the question: research toward histone deacetylase inhibitors

Research Articles

Petalidis, L.P. et al.

Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data

Katsoulas, A. et al.

Combi-targeting concept: an optimized single-molecule dual-targeting model for the treatment of chronic myelogenous leukemia

Kotecha, M. et al.

Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepinepolyamide conjugate GWL-78

Beltran, A.S. et al.

Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor

Samudio, I. et al.

Inhibition of mitochondrial metabolism by methyl-2-cyano-3,12-dioxooleana-1, 9-diene-28-oate induces apoptotic or autophagic cell death in chronic myeloid leukemia cells

Bian, T. et al.

Human papillomavirus type 16 L1E7 chimeric capsomeres have prophylactic and therapeutic efficacy against papillomavirus in mice

So, P-L. et al.

Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis

D’Alise, A.M. et al.

Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells

Wang, H. et al.

Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein

Oguri, T. et al.

MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer

Schiappacassi, M. et al.

p27Kip1 expression inhibits glioblastoma growth, invasion, and tumor-induced neoangiogenesis

Wang, X. et al.

Akt-mediated eminent expression of c-FLIP and Mcl-1 confers acquired resistance to TRAIL-induced cytotoxicity to lung cancer cells

Li, X. et al.

Requirement of hypoxia-inducible factor-1 down-regulation in mediating the antitumor activity of the anti–epidermal growth factor receptor monoclonal antibody cetuximab

Lin, C-W. et al.

Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9

Liu, G. et al.

An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector

Gao, R. et al.

Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1

Lipka, D.B. et al.

LS104, a non-ATP-competitive small-molecule inhibitor of JAK2, is potently inducing apoptosis in JAK2V617F-positive cells

Hu, S. et al.

Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia

Raina, K. et al.

Chemopreventive effects of oral gallic acid feeding on tumor growth and progression in TRAMP mice

Lu, L. et al.

Vitamin D3 analogue EB1089 inhibits the proliferation of human laryngeal squamous carcinoma cells via p57

Mijatovic, T. et al.

Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity

Newbold, A. et al.

Characterisation of the novel apoptotic and therapeutic activities of the histone deacetylase inhibitor romidepsin

Madhunapantula, S.V. et al.

PBISe, a novel selenium-containing drug for the treatment of malignant melanoma

Weisberg, E. et al.

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells

Johansson, G. et al.

Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors

Hassig, C.A. et al.

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo

Kandasamy, K. et al.

Proteasome inhibitor PS-341 (VELCADE) induces stabilization of the TRAIL receptor DR5 mRNA through the 3´-untranslated region

Casado, J.A. et al.

Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin

Liby, K. et al.

The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis

Alfano, R.W. et al.

Cytotoxicity of the matrix metalloproteinase–activated anthrax lethal toxin is dependent on gelatinase expression and B-RAF status in human melanoma cells

Chen, S-C. et al.

Plasminogen activator inhibitor-1 inhibits prostate tumor growth through endothelial apoptosis

Vultur, A. et al.

SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells

Zhu, N. et al.

Inhibition of the Akt/survivin pathway synergizes the antileukemia effect of nutlin-3 in acute lymphoblastic leukemia cells